Home - Products - Others - Other Targets - 3-O-acetyl-platyconic acid A (Platyconic acid B)

3-O-acetyl-platyconic acid A (Platyconic acid B)

CAS No. 1256935-28-0

3-O-acetyl-platyconic acid A (Platyconic acid B)( —— )

Catalog No. M31261 CAS No. 1256935-28-0

3''-O-acetyl-platyconic acid A is a natural product of Platycodon, Campanulaceae.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 351 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-O-acetyl-platyconic acid A (Platyconic acid B)
  • Note
    Research use only, not for human use.
  • Brief Description
    3''-O-acetyl-platyconic acid A is a natural product of Platycodon, Campanulaceae.
  • Description
    3''-O-acetyl-platyconic acid A is a natural product of Platycodon, Campanulaceae. 3''-O-acetyl-platyconic acid A can be used as a reference standard.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1256935-28-0
  • Formula Weight
    1281.4
  • Molecular Formula
    C59H92O30
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DS-1040 tosylate

    DS-1040 tosylate (DS1040)?is a small molecule inhibitor of the activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50 of 1.7 ng/mL for rabbit TAFIa.

  • Defensin HNP-2 (huma...

    Defensin HNP-2 human is an endogenous antibiotic peptide and monocyte chemotactic peptide produced by human neutrophils.

  • Emicizumab

    Emicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.